Olfactory neuroblastoma (esthesioneuroblastoma): towards minimally invasive surgery and multi-modality treatment strategies – an updated critical review of the current literature
G. X. Papacharalampous, P. V. Vlastarakos, A. Chrysovergis, P. K. Saravakos, G. P. Kotsis, D. I. Davilis; pp 557-563 (AbstractPDF)

Cisplatin: Process and Future
G.P. Stathopoulos; pp 564-569 (AbstractPDF)

Pharmacogenomics: Current applications and future prospects towards personalized therapeutics
A. Vaiopoulou, M. Gazouli, G. A. Karikas; pp 570-578 (AbstractPDF)



The importance of COX-2 expression as prognostic factor in early breast cancer
A.Kargi, M. Uysal , H. Bozcuk , H. S. Coskun , B. Savas , M. Ozdogan; pp 579-584  (AbstractPDF)

Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients
U.Y.Arslan, I.Turker, S.Aksoy, B.Oksuzoglu, K.Helvaci, N.Yildirim Ozdemir, U.Uyeturk, O.Uysal Sonmez, B. Budakoglu, N. Zengin; pp 585-593 (AbstractPDF)

CHEK2 1100delC and Del5395bp mutations in BRCAnegative individuals from Serbian hereditary breast and ovarian cancer families
A. Krivokuca, J. Dobricic, M. Brankovic-Magic; pp 594-600 (AbstractPDF)

The importance of pre-operative needle core breast biopsy results on resected tissue volume, margin status, and cosmesis
A. V. Polat, A. Soran, O. Andacoglu, A. Kamali Polat , K. McGuire, E. Diego, R. Johnson; pp 601-607 (AbstractPDF)

Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes
T. Kos, S. Aksoy, M.A.N. Sendur, Z. Arik, B. Civelek, N. Kandemir, N.Y. Ozdemir, N. Zengin, K. Altundag; pp 608-613 (AbstractPDF)

Oxidative and antioxidative status after anthracyclinebased chemotherapy in breast cancer patients
A. Alacacioglu, L. Kebapcilar, B. Onder Pamuk, G. Sop, C. Kucukiravul, G. Bozkaya, A. Yuksel, I. Alacacioglu , I. Sari; pp 614-618 (AbstractPDF)

Hormone receptor and HER2 status in patients with breast cancer by races in southeastern Turkey
A. Kuzhan, M. Adli, H. Eryigit Alkis, D. Caglayan; pp 619-622 (Abstract, PDF)


Procalcitonin in patients with colorectal cancer
D. Keramidaris, N. Koronakis, E.E. Lagoudianakis, A. Pappas, I. Koukoutsis, I. Chrysikos, G. Karavitis, K. Toutouzas, A. Manouras; pp 623-628 (AbstractPDF)

Chemotherapy compliance, tolerance and efficacy in elderly and non-elderly patients with metastatic colorectal cancer: A single institution comparative study
M. Bakogeorgos, G. Mountzios, G. Kotsantis, P. Economopoulou, N. Fytrakis, N.Kentepozidis; pp 629-634 (AbstractPDF)

AKAP12/Gravin gene expression in colorectal cancer: clinical importance and review of the literature
M. Yildirim, D. Suren, M. Yildiz, A. Sezgin Alikanoglu, R. Eryilmaz, S. Goktas, N. Bulbuller, C. Sezer; pp 635-640 (AbstractPDF)

Safety and efficacy of addition of bevacizumab to oxaliplatin-based preoperative chemotherapy in colorectal cancer with liver metastasis- a single institution experience
A. Cvetanovic, S. Vrbic, S. Filipovic, I. Pejcic, D. Milenkovic, N. Zivkovic; pp 641-646 (AbstractPDF)

Survival analysis of metastatic colorectal cancer patients who were treated with the five major therapeutic agents over the course of disease
U. Varol, Y. Cirak, B. Cakar, B. Karaca, C. Sezgin, R. Uslu, B. Karabulut; pp 647-652 (AbstractPDF)


ErbB2, ErbB3 and ErbB4 expression in urothelial tumors of the upper urinary tract and their prognostic significance
I. Galanakis, E. Spyropoulos, I. Gkialas, A. Nomikos, E. Souka, D. Mitropoulos; pp 653-659 (AbstractPDF)

Evaluation of the clinical value of the newly identified urine biomarker HIST1H4K for diagnosis and prognosis of prostate cancer in Bulgarian patients
D. Kachakova, A. Mitkova, E. Popov, O. Beltcheva, A. Vlahova, T. Dikov, S. Hristova, V. Mitev, C. Slavov, R. Kaneva; pp 660-668 (AbstractPDF)

Treatment of high risk prostate cancer with combined radiotherapy and hormonal treatment– results and identification of factors influencing outcome
J. Kubes, K. Dedeckova, J. Cvek, V. Vondráček, J. Dvořák, S. Argalacsová, M. Navrátil, J. Buril; pp 669-674 (AbstractPDF)


Effect of trichosanthin on apoptosis and telomerase activity of nasopharyngeal carcinomas in nude mice
Min Kang, Hesheng Ou, Rensheng Wang, Wenqi Liu, Yan Mao, Anzhou Tang; pp 675-682 (AbstractPDF)

Laryngeal dysplasia: A long-term follow-up study
M. G. Theodosiou, J. Yiotakis, C. Dikoglou, A. C. Lazaris, A. Athanasiadis- Sismanis, J. Xenellis; pp 683-688 (AbstractPDF)


Therapeutic effect of laparoscopy-assisted D2 radical gastrectomy in 106 patients with advanced gastric cancer
Zhi-Xiong Li, Yan-Chang Xu, Wen-Lin Lin, Jian Chen, Hai-Yan Wu; pp 689-694 (AbstractPDF)

KLF4 expression and apoptosis-related markers in gastric cancer
M. Krstic, S. Stojnev, I. Jovanovic, G.Marjanovic; pp 695-702 (AbstractPDF)

Correlation of the ICG test with risk factors and postoperative outcomes following hepatic resection
M. K. Derpapas, J. Contis, G. P. Fragulidis, P. M. Lykoudis, G. Polymeneas, S. Ntourakis, D. Voros; pp 703-707 (AbstractPDF)

In which cases surgical gastrostomy and jejunostomy techniques are inevitable?
K. Bora Yilmaz, L. Dogan, M. Akinci, C. Atalay, N. Karaman, O. Canoler, C. Ozaslan, H. Kulacoglu; pp 708-712 (AbstractPDF)


Radiation enhancing effects with the combination of sanazole and irinotecan in hypoxic HeLa human cervical cancer cell line
Yue-Can Zeng, Li Yu, Yu-Ping Xiao,Yan Xin, Nai-Qian Wang, Xiao-Ye Zhang, Li Zhao; pp 713-716 (AbstractPDF)


Evaluation of linear accelerator-based stereotactic radiosurgery in the management of meningiomas: a single center experience
F. Dincoglan, M. Beyzadeoglu , O. Sager, B. Uysal, S. Demiral, H. Gamsiz, B. Dirican; pp 717-722 (AbstractPDF)


Mortality from cancer of the lung in Serbia
M. Ilic, H. Vlajinac, J. Marinkovic, Z. Blazic; pp 723-727 (AbstractPDF)

Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer
M. Yildirim, M. Yildiz, E. Duman, S. Goktas, V. Kaya; pp 728-732 (AbstractPDF)


Central lymph node metastasis in cN0 papillary thyroid carcinoma
YingJie Wu, JiaLei Gu, JinBiao Shang, WenDong Wang, KeJing Wang; pp 733-738 (AbstractPDF)


The role of flow cytometry in the diagnosis of non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, granulomatous inflammation and reactive lymph node specimens
E. Gunduz, M. Celebioglu, O. Meltem Akay, H. Uskudar Teke, F. Sahin Mutlu, Z. Gulbas; pp 739-745 (AbstractPDF)


Informing cancer patient based on his type of personality: The suspicious (paranoid) patient
G. Kallergis; pp 746-750 (AbstractPDF)

The influence of distressing symptoms to levels of depression in cancer patients
K. Mystakidou, E. Parpa, E. Tsilika, I. Panagiotou, A. Galanos, A. Gouliamos; pp 751-759 (AbstractPDF)

An evaluation of lifestyle changes in cancer patients after diagnosis
N.S. Turhal, M. Koyyeri, B. Kahraman, M. Binici, M. Yilmaz, M. Kocar; pp 760-766 (AbstractPDF)

Depression and anxiety in cancer patients and their relatives
A. Alacacioglu, O. Tarhan, I. Alacacioglu, A. Dirican, U. Yilmaz; pp 767-774 (AbstractPDF)


Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib
F. Sen, I. Yildiz, M. Basaran, M. Ekenel, F. Oz, L. Kilic, B. Toz, A. Gurdal, H. Camlica, S. Bavbek, H. Oflaz; pp 775-781 (AbstractPDF)

Risk factors for recurrence and survival in patients with primary retroperitoneal tumors
Bing Li, Cheng-Hua Luo, Wei Zheng; pp 782-787 (AbstractPDF)

Magnetic resonance imaging and image analysis of post -radiation changes of bone marrow in patients with skeletal metastases
O. Romanos, E. Solomou, P. Georgiadis, D. Kardamakis, D. Siablis;pp 788-794 (AbstractPDF)


Legal, cultural and ethical considerations on the informing of the cancer patient: a perspective from Greece
L. Kousathana, F. Kousathana, M. Karamanou, A.A. Kousoulis; pp 795-797 (AbstractPDF)


Medullary carcinoma of the breast: A brief report from a tertiary care center
I. Petekkaya, T. Babacan, F. Sarici, G. Gezgen, E.C. Roach, M.C. Kizilarslanoglu, K. Altundag; p 798 (AbstractPDF)

Successful treatment of benign metastasizing leiomyoma with oral alternated chemotherapeutic agents
F. Sarici, T. Babacan, K. Altundag, O. Balakan, I. Gullu; p 799 (AbstractPDF)

Lung tuberculosis causing false positivity on positron emission tomography
S. Muallaoglu, I. Ustun, Y. Kaya, I. Leblebici; p 800 (AbstractPDF)

Does trastuzumab-emtansine have better cardiac safety profile in contrast to trastuzumab?
M.A.N. Sendur, S. Aksoy, Y. Ozdemir, N. Zengin, K. Altundag; p 801 (AbstractPDF)


Re-irradiation for recurrent head and neck carcinomas (by Dr. Peponi et al);
Dr. Jon Cacicedo Fernandez de Bobadilla; p 802 (AbstractPDF)

Reply to Dr. Jon Cacicedo Fernandez de Bobadilla;
Dr. E. Peponi; p 803 (AbstractPDF)

Significance of the resection margin and risk factors for close or positive resection margin in patients undergoing breast-conserving surgery (by Drs Gatek and Vrana)
Dr. Charalampos Seretis; pp 803-804 (AbstractPDF)

Reply to Dr. Charalampos Seretis;
Drs Gatek and Vrana; p 804 (AbstractPDF)


Aretaeus of Cappadocia and the first accurate description of uterine carcinoma
G. Tsoucalas, M. Karamanou, K. Laïos, G. Androutsos; pp 805-807 (AbstractPDF)

In the article “The role of VEGF and other parameters in tracking the clinical course of metronomic chemotherapy”,
which appeared in vol.18, no.1, pp 245-252, 2013 issue, the name of the first author D. Ekici should
be D. Ekinci, and the name of Didem Yalcin A should be Arzu Didem Yalcin. The authors of the article apologize
for their mistake.